Citadel Advisors’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
RCI
SCM
BCM
FIS
Citadel Advisors's REPL Position: Q2 2026 in Review
Citadel Advisors increased its Replimune Group (REPL) stake by 97% in Q2 2026, buying an estimated $2.36M and bringing the position to 784,233 shares worth $8.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3790.
Citadel Advisors first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. The position peaked at $44.4M in Q4 2020. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- Citadel Advisors held 784,233 shares of Replimune Group worth $8.68M as of Q2 2026.
- Citadel Advisors bought 385,504 Replimune Group shares in Q2 2026, an estimated $2.36M.
- Replimune Group made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #3790 holding.
- Citadel Advisors first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
- Citadel Advisors's Replimune Group position peaked at $44.4M in Q4 2020.
- 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.